MAGEA4 and neoplasm: Collectively, these data suggesting high MAGE-A4 prevalence and/or abundance in several tumor types may help to inform the direction of future research programs that are targeting the MAGE-A4 antigen in patients with unresectable and/or metastatic solid cancers.